
Intelligent Bio Solutions fell 74.5% from $6.91 to $1.76, behind the S&P 500's +13.3%. Its worst day was Jan 21 (−28.5%), and its low came Oct 15 at $1.44.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Intelligent Bio Solutions shares rose 132.4%, while the S&P 500 fell 0.7%.
+132.4%, the year's best day, on 108M shares, the year's heaviest volume · S&P 500 −0.7%
Story events cover the past 12 months · Times ET
Intelligent Bio Solutions closed at its highest level of the year, 159.3% above where the year started.
+25.2% · S&P 500 +0.7%
Intelligent Bio Solutions shares fell 28.5%, while the S&P 500 rose 1.2%.
−28.5%, the year's worst day · S&P 500 +1.2%
EPS of $-2.82 was reported on $896,774.00 revenue.
−6.7% · S&P 500 −1.5%
EPS of $-1.80 was reported on $1.1M revenue.
+25.5% · S&P 500 +0.6%
EPS of $-0.90 beat the $-1.58 estimate on $1.1M revenue (est. $1.2M).
−17.1% · S&P 500 +0.2%
Intelligent Bio Solutions closed at its lowest level of the year, 79.2% below where the year started.
−0.7% · S&P 500 +0.3%
EPS of $-0.86 beat the $-1.31 estimate on $1.4M revenue (est. $1.4M).
−1.7% · S&P 500 −0.4%
Where it ended: a close of $1.76 on Nov 13, 2026. Up next: Q2 2027 earnings on Feb 11, 2027 (EPS est. $-1.36, revenue est. $1.4M).
Nothing in the past 12 months.
All INBS analyst actionsNothing in the past 12 months.
All INBS dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for INBS and SPY from Benzinga historical bars. Not investment advice.